The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study
- Conditions
- on-Alcoholic Fatty Liver Disease
- Registration Number
- SLCTR/2018/042
- Lead Sponsor
- Durdans Hospital, 3, Alfred place, Colombo 3
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Subjects who are diagnosed to have NAFLD by a medical officer or a medical consultant [based on hepatic ultrasonography and elevated levels (>1.5xUpper Limit) of alanine aminotransferase (ALT) concentration] and are referred to a registered Dietician & Nutritionist.
Age between 30-55 years
Subjects having other acute or chronic liver diseases of other etiologies (viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hereditary haemochromatosis, Wilson's disease, drug induced liver injury; cholestasis).
Subjects who are pregnant and / or lactating
Subjects who have history of malignancy, history of significant alcohol consumption (>14 units/week for men, >7 units/week for females)
Subjects who are taking antibiotics, probiotics, vitamin, mineral, antioxidants, omega-3 or any other food supplements preceding enrollment
Subjects who are on treatment with vitamin E, statins within 3 months prior to the starting date of the research.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in levels of Aspartate Transaminase (AST), Alanine Transaminase (ALT) and Gamma Glutamyl Transpeptidase (GGT). [At the baseline of the study and at 8 weeks]<br>
- Secondary Outcome Measures
Name Time Method Change in weight and BMI. <br>Change in dietary measures (assessed using 24-h dietary recalls and semi quantitative food frequency questionnaire)<br>Change in physical activity ( assessed using Short Form of the International Physical Activity Questionnaire.<br> [At the baseline of the study and at 8 weeks]<br>